Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis

References

• Chen HY, Yang YS, Hsu WJ, et al. Emergence of carbapenem-resistant Acinetobacter nosocomialis strain ST410 harbouring plasmid-borne blaOXA-72 gene in Taiwan. Clin Microbiol Infect. 2018 Sep;24(9):1023–1024.
   Web of Science ®Google Scholar
• Singkham-In U, Chatsuwan T. Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand. J Med Microbiol. 2018 Dec;67(12):1667–1672.
   Web of Science ®Google Scholar
• Chen FJ, Huang WC, Liao YC, et al. Molecular epidemiology of Emerging carbapenem resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02007–18.
   Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008 Jul;21(3):538–582.
   PubMed Web of Science ®Google Scholar
• Qureshi ZA, Hittle LE, O'Hara JA, et al. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis. 2015 May 1;60(9):1295–1303.
   PubMed Web of Science ®Google Scholar
• Elham B, Fawzia A. Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome. Afr Health Sci. 2019 Sep;19(3):2400–2406.
   PubMed Web of Science ®Google Scholar
• Gales AC, Seifert H, Gur D, et al. Antimicrobial susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii complex and stenotrophomonas maltophilia clinical isolates: results from the SENTRY antimicrobial surveillance program (1997-2016). Open Forum Infect Dis. 2019 Mar;6(Suppl 1):S34–S46.
   PubMed Web of Science ®Google Scholar
• Lee YT, Sun JR, Wang YC, et al. Multicentre study of risk factors for mortality in patients with Acinetobacter bacteraemia receiving colistin treatment. Int J Antimicrob Agents. 2020 Jun;55(6):105956.
   Web of Science ®Google Scholar
• Snyman Y, Reuter S, Whitelaw AC, et al. Characterisation of mcr-4.3 in a colistin-resistant Acinetobacter nosocomialis clinical isolate from Cape Town, South Africa. J Glob Antimicrob Resist. 2021 Jun;25:102–106.
   Web of Science ®Google Scholar
• Lee YT, Huang LY, Chiang DH, et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents. 2009 Dec;34(6):580–584.
   Web of Science ®Google Scholar
• Nemec A, Dijkshoorn L. Variations in colistin susceptibility among different species of the genus acinetobacter. J Antimicrob Chemother. 2010 Feb;65(2):367–369.
   PubMed Web of Science ®Google Scholar
• Yang YS, Lee YT, Tsai WC, et al. Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis. BMC Infect Dis. 2013 Jul 10;13(311.
   Google Scholar
• Wang YC, Lee YT, Yang YS, et al. Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure. Clin Microbiol Infect. 2015 Aug;21(8):758–764.
   PubMed Web of Science ®Google Scholar
• Arroyo LA, Herrera CM, Fernandez L, et al. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother. 2011 Aug;55(8):3743–3751.
   PubMed Web of Science ®Google Scholar
• Gerson S, Lucassen K, Wille J, et al. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii. Int J Antimicrob Agents. 2020 Mar;55(3):105862.
   Web of Science ®Google Scholar
• Adams MD, Nickel GC, Bajaksouzian S, et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother. 2009 Sep;53(9):3628–3634.
   PubMed Web of Science ®Google Scholar
• Moffatt JH, Harper M, Adler B, et al. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011 Jun;55(6):3022–3024.
   PubMed Web of Science ®Google Scholar
• Moffatt JH, Harper M, Harrison P, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010 Dec;54(12):4971–4977.
   PubMed Web of Science ®Google Scholar
• Carretero-Ledesma M, Garcia-Quintanilla M, Martin-Pena R, et al. Phenotypic changes associated with colistin resistance due to lipopolysaccharide loss in Acinetobacter baumannii. Virulence. 2018 Dec 31;9(1):930–942.
   PubMed Web of Science ®Google Scholar
• Nurtop E, Bayindir Bilman F, Menekse S, et al. Promoters of colistin resistance in Acinetobacter baumannii infections. Microb Drug Resist. 2019 Sep;25(7):997–1002.
   Web of Science ®Google Scholar
• Bartual SG, Seifert H, Hippler C, et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005 Sep;43(9):4382–4390.
   PubMed Web of Science ®Google Scholar
• Feil EJ, Li BC, Aanensen DM, et al. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2004 Mar;186(5):1518–1530.
   PubMed Web of Science ®Google Scholar
• Rebelo AR, Bortolaia V, Kjeldgaard JS, et al. Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes. Euro Surveill. 2018 Feb;23(6.
   PubMedGoogle Scholar
• Sun JR, Chiang YS, Shang HS, et al. Phenotype microarray analysis of the AdeRS two-component system in Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2343–2353.
   PubMed Web of Science ®Google Scholar
• Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252–W258.
   PubMed Web of Science ®Google Scholar
• Arnold K, Bordoli L, Kopp J, et al. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006 Jan 15;22(2):195–201.
   PubMed Web of Science ®Google Scholar
• Mechaly AE, Sassoon N, Betton JM, et al. Segmental helical motions and dynamical asymmetry modulate histidine kinase autophosphorylation. PLoS Biol. 2014 Jan;12(1):e1001776.
   PubMed Web of Science ®Google Scholar
• Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126–2132.
   PubMedGoogle Scholar
• Chuang YC, Cheng A, Sun HY, et al. Microbiological and clinical characteristics of Acinetobacter baumannii bacteremia: implications of sequence type for prognosis. J Infect. 2019 Feb;78(2):106–112.
   PubMed Web of Science ®Google Scholar
• Al-Kadmy IMS, Ibrahim SA, Al-Saryi N, et al. Prevalence of genes involved in colistin resistance in Acinetobacter baumannii: first report from Iraq. Microb Drug Resist. 2020 Jun;26(6):616–622.
   Web of Science ®Google Scholar
• Ma F, Shen C, Zheng X, et al. Identification of a novel plasmid carrying mcr-4.3 in an Acinetobacter baumannii strain in China. Antimicrob Agents Chemother. 2019 Jun;63(6.
   Web of Science ®Google Scholar
• Sun JR, Jeng WY, Perng CL, et al. Single amino acid substitution Gly186Val in AdeS restores tigecycline susceptibility of Acinetobacter baumannii. J Antimicrob Chemother. 2016 Jun;71(6):1488–1492.
   Web of Science ®Google Scholar
• Sun Y, Cai Y, Liu X, et al. The emergence of clinical resistance to tigecycline. Int J Antimicrob Agents. 2013 Feb;41(2):110–116.
   PubMed Web of Science ®Google Scholar